glp-1 drugs long term effects GI Adverse of Glucagon-Like Peptide-1 Receptor Agonists Three major reviews commissioned by

Description

The various approaches include the combination of GLP-1R agonists with leptin [912,913], salmon calcitonin [914], PYY [915], CCK [916], insulin [917], adrenomedullin [918], and 3-adrenergic receptor agonists [919], and antagonists at the cannabinoid receptor 1 (CB1) [920], or agonists at the receptors for melanocortin-4 (MC4R) [685] or farnesoid-x (FXR) [921]

The UK Association of Anaesthetists published comprehensive multidisciplinary consensus in January 2025, recommending that GLP-1 receptor agonists be continued before surgery with individualised risk assessment [42]

These data align with an integrated analysis of 36 clinical studies that affirmed cardiovascular safety with up to 4-years treatment with either DPP-4 inhibitors or GLP-1R agonists [655]

Announcing the preclinical milestone, Nimbus signaled that it was looking beyond cardiometabolic disorders, into weight loss and management: I look forward to continuing to apply Nimbus discovery engine to address targets across metabolic, cardiovascular, and obesity-related diseases, Peter J